Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (4): 459-467.doi: 10.19982/j.issn.1000-6621.20250413
• Original Articles • Previous Articles Next Articles
Liu Xi1, Liu Yuze2, Hua Weiyu1, Li Jie1, Zhang Ying1, Dong Bin3(
)
Received:2025-10-23
Online:2026-04-10
Published:2026-04-02
Contact:
Dong Bin,Email:bindong@bjmu.edu.cn
CLC Number:
Liu Xi, Liu Yuze, Hua Weiyu, Li Jie, Zhang Ying, Dong Bin. Epidemiological characteristics of pulmonary tuberculosis among residents in Haidian District,Beijing from 2012 to 2022 and its correlation with population density[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 459-467. doi: 10.19982/j.issn.1000-6621.20250413
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250413
| 年份 | 人口数(万名) | 例数(占比) | CIR(/10万) | ASIR(/10万) |
|---|---|---|---|---|
| 2012 | 335.82 | 1452(0.13) | 43.24 | 44.68 |
| 2013 | 342.81 | 1291(0.11) | 37.66 | 38.53 |
| 2014 | 350.60 | 1241(0.11) | 35.40 | 36.36 |
| 2015 | 356.88 | 1200(0.10) | 33.63 | 35.00 |
| 2016 | 369.40 | 1110(0.10) | 30.05 | 30.96 |
| 2017 | 369.81 | 1168(0.10) | 31.58 | 33.13 |
| 2018 | 348.00 | 988(0.09) | 28.39 | 29.95 |
| 2019 | 335.80 | 838(0.07) | 24.96 | 25.84 |
| 2020 | 323.70 | 730(0.06) | 22.55 | 23.46 |
| 2021 | 313.35 | 885(0.08) | 28.24 | 27.27 |
| 2022 | 312.40 | 754(0.07) | 24.14 | 21.24 |
| 合计 | 3758.57 | 11657(1.00) | 31.01 | 31.49 |
| EAPC(%,95%CI) | -1.03(-2.09~0.04) | -6.35(-7.96~-4.71) | -5.37(-7.04~-3.67) | -6.21(-7.62~-4.78) |
| t值 | -2.182 | -8.549 | -8.312 | -9.630 |
| P值 | 0.057 | <0.001 | <0.001 | <0.001 |
| 年份 | 男性 | 女性 | ||||||
|---|---|---|---|---|---|---|---|---|
| 人口数 (万) | 例数 (占比) | CIR (/10万) | ASIR (/10万) | 人口数 (万名) | 例数 (占比) | CIR (/10万) | ASIR (/10万) | |
| 2012 | 173.17 | 916(0.13) | 52.90 | 56.54 | 162.65 | 536(0.12) | 32.95 | 32.88 |
| 2013 | 176.97 | 836(0.12) | 47.24 | 49.69 | 165.84 | 455(0.10) | 27.44 | 27.28 |
| 2014 | 180.84 | 794(0.11) | 43.91 | 46.83 | 169.76 | 447(0.10) | 26.33 | 26.09 |
| 2015 | 180.37 | 747(0.10) | 41.41 | 44.80 | 176.51 | 453(0.10) | 25.66 | 25.67 |
| 2016 | 189.39 | 696(0.10) | 36.75 | 38.89 | 180.01 | 414(0.09) | 23.00 | 23.08 |
| 2017 | 189.29 | 725(0.10) | 38.30 | 41.18 | 180.52 | 443(0.10) | 24.54 | 25.16 |
| 2018 | 177.28 | 582(0.08) | 32.83 | 36.48 | 170.72 | 406(0.09) | 23.78 | 23.72 |
| 2019 | 170.57 | 496(0.07) | 29.08 | 32.50 | 165.23 | 342(0.08) | 20.70 | 19.97 |
| 2020 | 164.14 | 452(0.06) | 27.54 | 30.69 | 159.56 | 278(0.06) | 17.42 | 16.99 |
| 2021 | 156.21 | 520(0.07) | 33.29 | 34.17 | 157.14 | 365(0.08) | 23.23 | 21.55 |
| 2022 | 155.70 | 429(0.06) | 27.55 | 23.79 | 156.70 | 325(0.07) | 20.74 | 18.79 |
| 合计 | 1913.93 | 7193(1.00) | 37.35 | 39.67 | 1844.64 | 4464(1.00) | 24.16 | 23.70 |
| EAPC (%,95%CI) | -1.35 (-2.47~ -0.23) | -7.34 (-8.84~ -5.81) | -6.06 (-7.65~ -4.45) | -6.84 (-8.40~ -5.27) | -0.70 (-1.72~ 0.33) | -4.78 (-6.77~ -2.75) | -4.11 (-6.12~ -2.06) | -4.88 (-6.70~ -3.02) |
| t值 | -2.712 | -10.548 | -8.312 | -9.545 | -1.537 | -5.250 | -4.487 | -5.842 |
| P值 | 0.024 | <0.001 | <0.001 | <0.001 | 0.159 | <0.001 | 0.002 | <0.001 |
| 年份 | 0~24岁 | 25~34岁 | 35~44岁 | 45~54岁 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 人口数 (万) | 例数 (占比) | CIR (/10万) | 人口数 (万) | 例数 (占比) | CIR (/10万) | 人口数 (万) | 例数 (占比) | CIR (/10万) | 人口数 (万) | 例数 (占比) | CIR (/10万) | |||||||||
| 2012 | 111.20 | 437(0.30) | 39.30 | 75.34 | 340(0.23) | 45.13 | 49.93 | 166(0.11) | 33.25 | 43.50 | 1360(0.09) | 31.27 | ||||||||
| 2013 | 112.06 | 315(0.24) | 28.11 | 77.54 | 345(0.27) | 44.49 | 47.69 | 143(0.11) | 29.98 | 46.23 | 137(0.11) | 29.63 | ||||||||
| 2014 | 114.60 | 275(0.22) | 24.00 | 79.30 | 354(0.29) | 44.64 | 48.78 | 112(0.09) | 22.96 | 47.28 | 142(0.11) | 30.03 | ||||||||
| 2015 | 116.62 | 251(0.21) | 21.52 | 80.67 | 325(0.27) | 40.29 | 49.65 | 114(0.10) | 22.96 | 48.11 | 118(0.10) | 24.53 | ||||||||
| 2016 | 119.38 | 217(0.20) | 18.18 | 82.49 | 306(0.28) | 37.09 | 50.74 | 102(0.09) | 20.10 | 49.19 | 112(0.10) | 22.77 | ||||||||
| 2017 | 121.95 | 202(0.17) | 16.56 | 81.19 | 279(0.24) | 34.36 | 49.94 | 139(0.12) | 27.83 | 48.41 | 136(0.12) | 28.09 | ||||||||
| 2018 | 114.57 | 145(0.15) | 12.66 | 75.46 | 213(0.22) | 28.23 | 46.42 | 116(0.12) | 24.99 | 45.00 | 93(0.09) | 20.67 | ||||||||
| 2019 | 64.58 | 97(0.12) | 15.02 | 103.17 | 191(0.23) | 18.51 | 48.41 | 91(0.11) | 18.80 | 51.62 | 78(0.09) | 15.11 | ||||||||
| 2020 | 55.50 | 68(0.09) | 12.25 | 99.29 | 134(0.18) | 13.50 | 49.33 | 93(0.13) | 18.85 | 49.67 | 83(0.11) | 16.71 | ||||||||
| 2021 | 58.98 | 99(0.11) | 16.79 | 84.39 | 190(0.21) | 22.51 | 44.27 | 86(0.10) | 19.43 | 45.52 | 91(0.10) | 19.99 | ||||||||
| 2022 | 110.59 | 50(0.07) | 4.52 | 64.66 | 149(0.20) | 23.04 | 55.94 | 85(0.11) | 15.20 | 45.49 | 97(0.13) | 21.32 | ||||||||
| 合计 | 1100.03 | 2156(1.00) | 18.99 | 903.50 | 2826(1.00) | 31.98 | 541.10 | 1247(1.00) | 23.12 | 520.02 | 1223(1.00) | 23.65 | ||||||||
| EAPC(%) | -5.30 | -18.10 | -13.52 | 0.59 | -9.39 | -9.93 | 0.15 | -5.53 | -5.67 | 0.33 | -14.68 | -5.58 | ||||||||
| 95%CI (%) | -10.59~ 0.30 | -21.26~ -14.81 | -18.83~ -7.85 | -2.27~ 3.54 | -12.21~ -6.49 | -14.19~ -5.46 | -1.16~ 1.48 | -8.02~ -2.98 | -8.42~ -2.85 | -0.79~ 1.46 | -25.50~ -2.28 | -8.76~ -2.29 | ||||||||
| t值 | -2.145 | -11.474 | -5.180 | 0.464 | -7.065 | -4.881 | 0.257 | -4.831 | -4.477 | 0.665 | -2.648 | -3.790 | ||||||||
| P值 | 0.061 | <0.001 | <0.001 | 0.653 | <0.001 | <0.001 | 0.803 | <0.001 | 0.002 | 0.523 | 0.027 | 0.004 | ||||||||
| 年份 | 55~64岁 | 65~74岁 | ≥75岁 | |||||||||||||||||
| 人口数 (万) | 例数 (占比) | CIR (/10万) | 人口数 (万) | 例数 (占比) | CIR (/10万) | 人口数 (万) | 例数 (占比) | CIR (/10万) | ||||||||||||
| 2012 | 27.30 | 130(0.09) | 47.61 | 16.55 | 98(0.07) | 59.20 | 12.00 | 145(0.10) | 120.84 | |||||||||||
| 2013 | 29.75 | 112(0.09) | 37.64 | 16.54 | 78(0.06) | 47.17 | 13.00 | 161(0.12) | 123.83 | |||||||||||
| 2014 | 30.43 | 107(0.09) | 35.16 | 16.91 | 76(0.06) | 44.94 | 13.30 | 175(0.14) | 131.60 | |||||||||||
| 2015 | 31.02 | 117(0.10) | 37.72 | 17.27 | 74(0.06) | 42.85 | 13.56 | 201(0.17) | 148.28 | |||||||||||
| 2016 | 31.67 | 131(0.12) | 41.37 | 20.12 | 86(0.08) | 42.75 | 15.81 | 156(0.14) | 98.67 | |||||||||||
| 2017 | 31.17 | 129(0.11) | 41.38 | 20.80 | 100(0.09) | 48.08 | 16.34 | 183(0.16) | 111.98 | |||||||||||
| 2018 | 28.98 | 131(0.13) | 45.20 | 21.04 | 95(0.10) | 45.16 | 16.53 | 195(0.20) | 118.00 | |||||||||||
| 2019 | 32.42 | 110(0.13) | 33.93 | 20.17 | 86(0.10) | 42.64 | 15.42 | 185(0.22) | 119.98 | |||||||||||
| 2020 | 34.93 | 109(0.15) | 31.21 | 19.65 | 84(0.12) | 42.75 | 15.33 | 159(0.22) | 103.70 | |||||||||||
| 2021 | 39.26 | 126(0.14) | 32.10 | 22.54 | 116(0.13) | 51.47 | 18.40 | 177(0.20) | 96.22 | |||||||||||
| 2022 | 40.10 | 117(0.16) | 29.18 | 26.77 | 109(0.14) | 40.71 | 19.36 | 147(0.19) | 75.93 | |||||||||||
| 合计 | 357.03 | 1319(1.00) | 37.50 | 218.36 | 1002(1.00) | 46.16 | 169.05 | 1884(1.00) | 113.66 | |||||||||||
| EAPC(%) | 3.18 | -0.11 | -3.19 | 4.13 | 2.60 | -1.47 | 4.18 | 0.20 | -3.83 | |||||||||||
| 95%CI (%) | 1.77~ 4.61 | -1.93~ 1.74 | -5.66~ -0.66 | 2.60~ 5.67 | -0.19~ 5.46 | -3.60~ 0.70 | 2.78~ 5.60 | -2.29~ 2.75 | -6.53~ -1.05 | |||||||||||
| t值 | 5.142 | -0.138 | -2.838 | 6.202 | 2.109 | -1.535 | 6.847 | 0.177 | -3.101 | |||||||||||
| P值 | <0.001 | 0.893 | 0.020 | <0.001 | 0.064 | 0.159 | <0.001 | 0.863 | 0.013 | |||||||||||
| [1] | 屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读. 结核与肺部疾病杂志, 2025, 6(6): 613-623. doi:10.19983/j.issn.2096-8493.20250178. |
| [2] | World Health Organization. The end TB strategy. Geneva: World Health Organization, 2015. |
| [3] | 国家疾病预防控制局, 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 等. 关于印发全国结核病防治规划(2024—2030年)的通知. 国疾控传防发〔2024〕19号. 2024-11-28. |
| [4] | 刘剑君, 么鸿雁, 刘二勇. 我国结核病疫情与社会经济因素的关系. 中华流行病学杂志, 2004, 25(12): 1032-1034. doi:10.3760/j.issn:0254-6450.2004.12.005. |
| [5] | Bekker LG, Wood R. The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. Clin Infect Dis, 2010, 50 Suppl 3: S208-S214. doi:10.1086/651493. |
| [6] | 毕圣贤, 胡锡健, 张辉国. 2014—2018年中国大陆结核病疫情的时空分布特征及其影响因素. 中华疾病控制杂志, 2021, 25(7): 758-762, 811. doi:10.16462/j.cnki.zhjbkz.2021.07.004. |
| [7] | 宋媛媛, 李涛, 夏辉, 等. 1997—2023年全国肺结核报告发病流行病学特征. 中国防痨杂志, 2024, 46(10):1198-1208. doi:10.19982/j.issn.1000-6621.20240382. |
| [8] |
Gupta M, Srikrishna G, Klein S, et al. Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Trends Immunol, 2022, 43(8): 640-656. doi:10.1016/j.it.2022.06.004.
pmid: 35842266 |
| [9] | 张世鹏, 张琪, 丁焕, 等. 江苏省无锡市2018—2020年学生肺结核疫情流行特征. 中国热带医学, 2022, 22(8): 744-747. doi:10.13604/j.cnki.46-1064/r.2022.08.11. |
| [10] | Viana PVS, Paiva NS, Villela DAM, et al. Factors associated with death in patients with tuberculosis in Brazil: competing risks analysis. PLoS One, 2020, 15(10): e0240090. doi:10.1371/journal.pone.0240090. |
| [11] |
Marçôa R, Ribeiro AI, Zão I, et al. Tuberculosis and gender-factors influencing the risk of tuberculosis among men and women by age group. Pulmonology, 2018, 24(3): 199-202. doi:10.1016/j.pulmoe.2018.03.004.
pmid: 29754721 |
| [12] | 杨超, 王晶, 唐桂林, 等. 2012—2021年北京市通州区流动人口肺结核流行特征及治疗转归分析. 中国防痨杂志, 2023, 45(6): 594-600. doi:10.19982/j.issn.1000-6621.20220502. |
| [13] |
Brassard P, Steensma C, Cadieux L, et al. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics, 2006, 117(2): e148-e156. doi:10.1542/peds.2005-1534.
pmid: 16452324 |
| [14] |
Piergallini TJ, Turner J. Tuberculosis in the elderly: Why inflammation matters. Exp Gerontol, 2018, 105: 32-39. doi:10.1016/j.exger.2017.12.021.
pmid: 29287772 |
| [15] | Allué-Guardia A, Torrelles JB, Sigal A. Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease. Front Immunol, 2023, 14: 1250198. doi:10.3389/fimmu.2023.1250198. |
| [16] | Vishnu Sharma M, Arora VK, Anupama N. Challenges in diagnosis and treatment of tuberculosis in elderly. Indian J Tuberc, 2022, 69 Suppl 2: S205-S208. doi:10.1016/j.ijtb.2022.10.001. |
| [17] | Velayutham BR, Nair D, Chandrasekaran V, et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB control programme in South India. PLoS One, 2014, 9(3): e88045. doi:10.1371/journal.pone.0088045. |
| [18] | Valsamis EM, Ricketts D, Husband H, et al. Segmented Linear Regression Models for Assessing Change in Retrospective Studies in Healthcare. Comput Math Methods Med, 2019, 2019:9810675. doi:10.1155/2019/9810675. |
| [19] |
Wang Y, Liu X, Li Y, et al. Association of urbanization-related factors with tuberculosis incidence among 1992 counties in China from 2005 to 2019: a nationwide observational study. Infect Dis Poverty, 2025, 14(1): 30. doi:10.1186/s40249-025-01299-4.
pmid: 40275405 |
| [20] | Talukdar T, Rathi V, Ish P. Geriatric tuberculosis in India-challenges and solutions. Indian J Tuberc, 2022, 69 Suppl 2: S209-S212. doi:10.1016/j.ijtb.2022.10.003. |
| [21] | 李雪, 姜世闻, 高永鑫, 等. 北京市流动人口肺结核患者确诊后未在首诊机构登记和治疗管理的原因分析. 中国防痨杂志, 2017, 39(1): 86-90. doi:10.3969/j.issn.1000-6621.2017.01.019. |
| [22] |
Najafizada M, Rahman A, Taufique Q, et al. Social determinants of multidrug-resistant tuberculosis: a scoping review and research gaps. Indian J Tuberc, 2021, 68(1): 99-105. doi:10.1016/j.ijtb.2020.09.016.
pmid: 33641859 |
| [23] | Xia L, Zhu S, Chen C, et al. Spatio-temporal analysis of socio-economic characteristics for pulmonary tuberculosis in Sichuan province of China, 2006—2015. BMC Infect Dis, 2020, 20(1): 433. doi:10.1186/s12879-020-05150-z. |
| [24] | 国家疾病预防控制局, 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 等. 关于印发遏制结核病行动计划(2019—2022年)的通知. 国疾控传防发〔2019〕41号. 2019-05-31. |
| [1] | . Guidelines for the diagnosis and treatment of superficial lymph node tuberculosis with integrated traditional Chinese and Western medicine [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 429-447. |
| [2] | Ji Lianrong, Xue Yunlian, Jiang Xue, Yuan Shasha, Liu Guihao, Wang Xiaowan, Zou Xia, Wang Tingting, Zhou Zhanqi, Zhou Lin. Spatio-temporal distribution and clustering characteristics of comorbidities among tuberculosis inpatients in Guangdong Province from 2016 to 2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 448-458. |
| [3] | Wang Yongbing, Zhong Yuexiang, Fu Xiuying, Zhang Ying, Weng Wenpei, Zhou Fangjing, Yang Yingzhou, Luo Jilun. Survey of Mycobacterium tuberculosis infection rate and analysis of associated factors among three priority populations in Yingde’s zero-TB community pilot areas,Guangdong Province [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 468-476. |
| [4] | Miao Honghao, Zhang Jie, Pang Mengdi, Ren Yixuan, Deng Yang, Yi Junli, Fan Ruifang, Chen Shuangshuang, Chen Hao, Yu Lan, Li Jie, Li Chuanyou, Yang Xinyu. Genotypic and drug resistance of Mycobacterium tuberculosis in Beijing,2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 477-484. |
| [5] | Li Jing, Zhang Yangyi, Yang Jinghui, Wu Zheyuan, Li Ningdi, Yu Chenlei, Wang Lili, Shen Xuhui, Jiang Yuan, Shen Xin. Study on the characteristics of rpoB gene mutations in Mycobacterium tuberculosis and its correlation with rifampicin resistance level in Shanghai [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 485-494. |
| [6] | Zhong Guowei, Zhang Shaoyi, Fan Huiling. Expression and clinical value of serum LncRNA LINC00707 and miR-382-5p in patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 495-503. |
| [7] | Jiang Lina, Dai Wenxi, Ju Hanfang, Meng Sukai, Wang Chunhua. Clinical value of auramine O fluorescence staining automatic microscopic scanning and recognition system for detecting tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 504-509. |
| [8] | Han Yanzhuo, Lu Zhenhui, Su Ben, Zhou Rui, Chen Jiajun, Wu Xianwei, Wu Dingzhong, Zhang Shaoyan, Qiu Lei. Analysis of the clinical characteristics of post-tuberculosis bronchiectasis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 510-517. |
| [9] | Gao Xianru, Cui Wenjuan, Zhang Mengran, Yang Kefan, Hao Huiyuan, Yang Lu, Sun Wenwen. Study on the health management journey map of 15 initially treated pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 518-524. |
| [10] | Yang Jie, Dong Ning, Wei Xiaowen, Wu Yan, Dong Wenfang, Wu Yuanhao, Zhang Lin. Effects of family participatory intervention on medication adherence and lung function based on health action process approach in elderly patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 525-533. |
| [11] | Du Fangfang, Cao Xuefang, Wang Jin, Jin Qi, Liu Jianjun, Gao Lei, Cheng Shiming. Analysis of current developing situation of group standards of Chinese Antituberculosis Association [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 534-540. |
| [12] | Zhou Wensi, Guo Meng, Chen Qingbo, Wang Quan, Li Wei. Comparative analysis of published literature in Chinese and English on multidrug-resistant tuberculosis from 2004 to 2025 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 541-549. |
| [13] | Qiu Yuxian, Huang Fang, Yang Xiaoyi, Yang Feng, Lu Hua, Zhang Tianyi, Zhang Yang, Yao Rong, Li Yuanyuan. Research progress in digital twin technology for tuberculosis patient management [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 550-555. |
| [14] | Shu Wei, Liu Yuhong. Interpretation of research and innovation part of the WHO Global Tuberculosis Report 2025 [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 307-312. |
| [15] | Wang Jing, Jing Wei, Li Weiwen, Zhu Qingdong, Pang Yu, Chu Naihui, Nie Wenjuan. Clinical cohort analysis of the efficacy and safety of extended-course bedaquiline in patients with multidrug-resistant/rifampicin-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 313-319. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.